HCA Healthcare Inc (NYSE:HCA) has been given an average rating of “Buy” by the twenty analysts that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, three have issued a hold rating and thirteen have issued a buy rating on the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $147.29.

HCA has been the topic of several recent research reports. BMO Capital Markets lowered HCA Healthcare from an “outperform” rating to a “market perform” rating and reduced their price target for the stock from $121.00 to $100.00 in a research report on Monday, July 13th. JPMorgan Chase & Co. raised their price target on HCA Healthcare from $142.00 to $161.00 and gave the stock an “overweight” rating in a research report on Friday, July 24th. SunTrust Banks lifted their target price on HCA Healthcare from $130.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, July 23rd. UBS Group reduced their target price on HCA Healthcare from $138.00 to $137.00 and set a “buy” rating on the stock in a report on Thursday, June 11th. Finally, Zacks Investment Research lowered HCA Healthcare from a “hold” rating to a “sell” rating and set a $103.00 target price on the stock. in a report on Tuesday, June 23rd.

Shares of HCA opened at $135.80 on Friday. The firm has a market capitalization of $45.90 billion, a price-to-earnings ratio of 14.00, a PEG ratio of 1.20 and a beta of 1.40. The company has a debt-to-equity ratio of 54.19, a quick ratio of 0.95 and a current ratio of 1.09. The business’s fifty day moving average price is $132.59 and its two-hundred day moving average price is $111.31. HCA Healthcare has a 52 week low of $58.38 and a 52 week high of $151.97.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Wednesday, July 22nd. The company reported $3.23 EPS for the quarter, beating the Zacks’ consensus estimate of ($0.94) by $4.17. The firm had revenue of $11.07 billion for the quarter, compared to analyst estimates of $10.44 billion. HCA Healthcare had a negative return on equity of 589.47% and a net margin of 6.67%. The business’s quarterly revenue was down 12.2% compared to the same quarter last year. During the same period last year, the company earned $2.21 EPS. As a group, research analysts forecast that HCA Healthcare will post 10.12 EPS for the current year.

In other news, SVP P. Martin Paslick sold 227 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $134.97, for a total transaction of $30,638.19. Following the completion of the sale, the senior vice president now owns 2,621 shares in the company, valued at $353,756.37. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider A Bruce Moore, Jr. sold 15,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $133.73, for a total value of $2,005,950.00. Following the completion of the sale, the insider now owns 88,626 shares of the company’s stock, valued at $11,851,954.98. The disclosure for this sale can be found here. Insiders have sold 15,481 shares of company stock valued at $2,070,363 in the last quarter. 1.80% of the stock is currently owned by corporate insiders.

Large investors have recently made changes to their positions in the company. Narwhal Capital Management boosted its holdings in HCA Healthcare by 2.2% in the 2nd quarter. Narwhal Capital Management now owns 4,121 shares of the company’s stock worth $400,000 after buying an additional 88 shares during the period. CWM Advisors LLC boosted its holdings in HCA Healthcare by 2.7% in the 1st quarter. CWM Advisors LLC now owns 3,840 shares of the company’s stock worth $345,000 after buying an additional 100 shares during the period. Alps Advisors Inc. boosted its holdings in HCA Healthcare by 3.8% in the 1st quarter. Alps Advisors Inc. now owns 2,904 shares of the company’s stock worth $261,000 after buying an additional 107 shares during the period. MML Investors Services LLC boosted its holdings in HCA Healthcare by 4.5% in the 1st quarter. MML Investors Services LLC now owns 2,976 shares of the company’s stock worth $267,000 after buying an additional 128 shares during the period. Finally, Private Capital Group LLC boosted its holdings in HCA Healthcare by 17.5% in the 1st quarter. Private Capital Group LLC now owns 866 shares of the company’s stock worth $78,000 after buying an additional 129 shares during the period. Institutional investors own 68.28% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: What is net income?

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.